Aducanumab, amyloid, and culture wars

BMJ. 2021 Aug 19:374:n2038. doi: 10.1136/bmj.n2038.
No abstract available

Publication types

  • Letter

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Amyloid / drug effects
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Drug Approval / legislation & jurisprudence*
  • Europe
  • Humans
  • Safety Management*
  • United Kingdom
  • United States

Substances

  • Amyloid
  • Antibodies, Monoclonal, Humanized
  • aducanumab